The significance of Bacillus anthracis as an agent of bioterrorism has been well established. An understanding of both the pathogenesis and the host response is required to elucidate approaches to more rapidly detect and effectively prevent or treat anthrax. Current vaccine strategies are focused primarily on production of antibodies against the protective antigen components of the anthrax toxins, which are secreted by the bacilli. A better understanding of the dynamic morphology of the dormant and germinating spore and its interaction with the host immune system could be important in developing an optimally efficacious anthrax vaccine. A spore-associated protein was identified that was specific to the Bacillus cereus group of bacteria and referred to as spore opsonization-associated antigen A (SoaA). Immuno-electron microscopy localized this protein to the area of the cortex beneath the coat of the dormant spore. Although our data suggested that SoaA was found below the coat layers of the ungerminated spore, SoaA was involved in the interaction of spores with macrophages shortly after infection. To investigate further the specific properties of the SoaA protein, the soaA gene was inactivated in the B. anthracis Ames strain. The SoaA protein in the Ames strain of B. anthracis increased the phagocytic uptake of the spores in the presence of anti-spore antibodies. Unlike the wild-type strain, the mutant soaA : : Kan strain was not readily opsonized by anti-spore antibodies. While the mutant spores retained characteristic resistance properties in vitro and virulence in vivo, the soaA : : Kan mutant strain was significantly less suited for survival in vivo when competed against the wild-type Ames strain.
AmayaE.,
KhvorovaA.,
PiggotP. J.2001; Analysis of promoter recognition directed by σ F of Bacillus subtilis by using random-sequence oligonucleotides. J Bacteriol 183:3623–3630
BozueJ. A.,
ParthasarathyN.,
PhillipsL. R.,
CoteC. K.,
FellowsP. F.,
MendelsonI.,
ShaffermanA.,
FriedlanderA. M.2005; Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb Pathog 38:1–12
BozueJ.,
CoteC. K.,
MoodyK. L.,
WelkosS. L.2007; Fully virulent Bacillus anthracis does not require the immunodominant protein, BclA, for pathogenesis. Infect Immun 75:508–511
BrachmanP. S.,
GoldH.,
PlotkinS. A.,
FeketyF. R.,
WerrinM.,
IngrahamN. R.1962; Field evaluation of a human anthrax vaccine. Am J Public Health 52:632–645
CoburnP. S.,
HancockL. E.,
BoothM. C.,
GilmoreM. S.1999; A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin. Infect Immun 67:3339–3347
CoteC. K.,
ReaK. M.,
NorrisS. L.,
van RooijenN.,
WelkosS. L.2004; The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37:169–175
CoteC. K.,
RossiC. A.,
KangA. S.,
MorrowP. R.,
LeeJ. S.,
WelkosS. L.2005; The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog 38:209–225
CowanA. E.,
OlivastroE. M.,
KoppelD. E.,
LoshonC. A.,
SetlowB.,
SetlowP.2004; Lipids in the inner membrane of dormant Bacillus species are largely immobile. Proc Natl Acad Sci U S A 101:7733–7738
DayW. A.Jr,
RasmussenS. L.,
CarpenterB. M.,
PetersonS. N.,
FriedlanderA. M.2007; Microarray analysis of transposon insertion mutations in Bacillus anthracis : global identification of genes required for sporulation and germination. J Bacteriol 189:3296–3301
FarchausJ. W.,
RibotW. J.,
JendrekS.,
LittleS. F.1998; Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis . Appl Environ Microbiol 64:982–991
FellowsP. F.,
LinscottM. K.,
IvinsB. E.,
PittM. L.,
RossiC. A.,
GibbsP. H.,
FriedlanderA. M.2001; Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241–3247
GominetM.,
SlamtiL.,
GiloisN.,
RoseM.,
LereclusD.2001; Oligopeptide permease is required for expression of the Bacillus thuringiensis plcR regulon and for virulence. Mol Microbiol 40:963–975
GoodinJ. L.,
RaabR. W.,
McKownR. L.,
CoffmanG. L.,
PowellB. S.,
EnamaJ. T.,
LigonJ. A.,
AndrewsG. P.2005; Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum. Protein Expr Purif 40:152–163
HelmannJ. D.,
MoranC. P.Jr2002; RNA polymerase and sigma factors. In Bacillus subtilis and its Closest Relatives. From Genes to Cells pp 289–312 Edited by
SonensheinA. L.,
HochJ. A.,
LosickR.
Washington, DC: American Society for Microbiology;
JacksonP. J.,
WalthersE. A.,
KalifA. S.,
RichmondK. L.,
AdairD. M.,
HillK. K.,
KuskeC. R.,
AndersenG. L.,
WilsonK. H.other authors1997; Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates. Appl Environ Microbiol 63:1400–1405
JedrzejasM. J.2002; The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: development of novel prophylactic and therapeutic agents. Crit Rev Biochem Mol Biol 37:339–373
KeimP.,
KalifA.,
SchuppJ.,
HillK.,
TravisS. E.,
RichmondK.,
AdairD. M.,
Hugh-JonesM.,
KuskeC. R.,
JacksonP.1997; Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol 179:818–824
KroghA.,
LarssonB.,
von HeijneG.,
SonnhammerE. L.2001; Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567–580
KudvaI. T.,
GriffinR. W.,
GarrenJ. M.,
CalderwoodS. B.,
JohnM.2005; Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect Immun 73:5685–5696
LittleS. F.,
KnudsonG. B.1986; Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect Immun 52:509–512
LittleS. F.,
WebsterW. M.,
IvinsB. E.,
FellowsP. F.,
NorrisS. L.,
AndrewsG. P.2004; Development of an in vitro-based potency assay for anthrax vaccine. Vaccine 22:2843–2852
MendelsonI.,
ToberyS.,
ScorpioA.,
BozueJ.,
ShaffermanA.,
FriedlanderA. M.2004; The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence. Microb Pathog 37:149–154
NicholsonW. L.,
SetlowP.1990; Sporulation, germination, and outgrowth. In Molecular Biological Methods for Bacillus pp 391–450 Edited by
HarwoodC. R.,
CuttingS. M.
New York: Wiley;
PagniM.,
IoannidisV.,
CeruttiL.,
Zahn-ZabalM.,
JongeneelC. V.,
FalquetL.2004; MyHits: a new interactive resource for protein annotation and domain identification. Nucleic Acids Res 32:W332–W335
PaidhungatM.,
SetlowP.1999; Isolation and characterization of mutations in Bacillus subtilis that allow spore germination in the novel germinant d-alanine. J Bacteriol 181:3341–3350
Perez-CasalJ.,
CaparonM. G.,
ScottJ. R.1991; Mry, a trans -acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol 173:2617–2624
PittmanP. R.,
Kim-AhnG.,
PifatD. Y.,
CoonanK.,
GibbsP.,
LittleS.,
Pace-TempletonJ. G.,
MyersR.,
ParkerG. W.,
FriedlanderA. M.2002; Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 20:1412–1420
RaskoD. A.,
RavelJ.,
OkstadO. A.,
HelgasonE.,
CerR. Z.,
JiangL.,
ShoresK. A.,
FoutsD. A.,
TourasseN. J.other authors2004; The genome of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic Acids Res 32:977–988
ReadT. D.,
PetersonS. N.,
TourasseN.,
BaillieL. W.,
PaulsenI. T.,
NelsonK. E.,
TettelinH.,
FoutsD. E.,
EisenJ. A.other authors2003; The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81–86
RedmondC.,
BaillieL. W. J.,
HibbsS.,
MoirA. J. G.,
MoirA.2004; Identification of proteins in the exosporium of Bacillus anthracis . Microbiology 150:355–363
SteichenC.,
ChenP.,
KearneyJ. F.,
TurnboughC. L.Jr2003; Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J Bacteriol 185:1903–1910
SylvestreP.,
Couture-TosiE.,
MockM.2002; A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol 45:169–178
SylvestreP.,
Couture-TosiE.,
MockM.2005; Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the Bacillus anthracis exosporium. J Bacteriol 187:5122–5128
WelkosS. L.,
TrotterR. W.,
BeckerD. M.,
NelsonG. O.1989; Resistance to the Sterne strain of B. anthracis : phagocytic cell responses of resistant and susceptible mice. Microb Pathog 7:15–35
WelkosS.,
LittleS.,
FriedlanderA.,
FritzD.,
FellowsP.2001; The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147:1677–1685
WelkosS.,
FriedlanderA.,
WeeksS.,
LittleS.,
MendelsonI.2002; In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 51:821–831
WelkosS. L.,
CoteC. K.,
ReaK. M.,
GibbsP. H.2004; A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Methods 56:253–265